Serum and tissue light-chains as disease biomarkers and targets for treatment in AL amyloidosis
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management | JACC: CardioOncology
Systemic immunoglobulin light chain amyloidosis | Nature Reviews Disease Primers
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
AL Amyloidosis | Amyloidosis Foundation
Journal of Lancaster General Health - Journal of Lancaster General Hospital
AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis | BMC Nephrology | Full Text
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics | Nature Communications
Exploring the sequence features determining amyloidosis in human antibody light chains | Scientific Reports
Molecular Mechanisms of Amyloidosis | NEJM
Hemato | Free Full-Text | Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis | BMC Nephrology | Full Text
Red Flag Presentations of Immunoglobulin Light Chain Amyloidosis in Patients With Multiple Myeloma - The ASCO Post
Kappa-light Chain Amyloid Overlapping Hypertrophic Cardiomyopathy With Myocardial Noncompaction | Circulation: Cardiovascular Imaging
Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients - ScienceDirect
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? | JACC: Cardiovascular Imaging
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
AL Amyloidosis (Primary Amyloidosis): Symptoms, Treatment & What it Is
What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021 | Blood Cancer Journal
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis - ScienceDirect
Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis – Consult QD
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy - ScienceDirect
